Please assess the completion status of the following clinical trial:

Trial Title: A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Subject has a history of genital HSV documented by laboratory testing at screening~* Subject has experienced 4 or more episodes of genital herpes during the past 12 months~Exclusion Criteria:~* Subject is immunocompromised

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Oral administration of active comparator
- 2 (Type: PLACEBO_COMPARATOR): Oral administration of placebo
- 3 (Type: EXPERIMENTAL): Dosing regimen 1
- 4 (Type: EXPERIMENTAL): Dosing regimen 2
- 5 (Type: EXPERIMENTAL): Dosing regimen 3
- 6 (Type: EXPERIMENTAL): Dosing regimen 4

Based on this trial design, predict the completion outcome and termination type (if applicable).